Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. BAJAJHFL:I
9. CCHGY
10. PRY:IM

Go back to Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
COGENT (NASDAQ: COGT) Delayed: 38.69 +0.21 (0.55%)
Previous Close $38.48    52 Week High $5.57 
Open $38.50    52 Week Low $2.90 
Day High $39.50    P/E 175.86 
Day Low $37.82    EPS $0.22 
Volume 1,858,903